Noema Pharma
PrivateLast Round
Series B
Extension
Dec 11, 2024
Total Funding Raised
$241M
Company Overview
Noema Pharma is a biotechnology company that develops innovative therapeutic solutions for central nervous system conditions, particularly targeting severe neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Noema Pharma Comparables
Compare Noema Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eumentis Therapeutics Inc. | 83% | |
| Addex Therapeutics | 82% | |
| Neurosterix | 79% |
Noema Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 11, 2024 | ||||
| Series B | Mar 7, 2023 | ||||
| Series A | Dec 1, 2020 |
Key People
Founding team and executive leadership
Noema Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioMedPartners | Series B, Series A |
| EQT Life Sciences | Series B Extension, Series B |
| Forbion | Series B |
| Gilde Healthcare | Series B, Series A, Series B Extension |
| Invus Opportunities | Series B, Series A, Series B Extension |
| Sofinnova Partners | Series B, Series B Extension, Seed, Series A |
| UPMC Enterprises | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2025
Michael Samar appointed as the new Chief Financial Officer.
- Mar 7, 2023
$147M round led by Jeito, EQT Life Sciences, and Forbion.
Noema Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Noema Pharma's valuation, stock price, and market status.
Is Noema Pharma a public or private company?
Noema Pharma is a private company.
What is the current stock price of Noema Pharma?
Noema Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Noema Pharma worth (valuation)?
Valuation information for Noema Pharma is not publicly available.
Can I buy Noema Pharma stock?
Noema Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Noema Pharma's last funding round?
Noema Pharma's most recent funding round was Series B Extension on December 11, 2024.
Who are the main investors in Noema Pharma?
Key investors in Noema Pharma include EQT Life Sciences, Sofinnova Partners, Polaris Partners, Jeito.
Will Noema Pharma IPO soon?
No public IPO plans have been announced for Noema Pharma.
How can I track Noema Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Noema Pharma's secondary market activity and sign up for updates.